These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34346192)

  • 1. Increased pulsatility index is associated with adverse outcomes in left ventricular assist device recipients.
    Tucanova Z; Ivak P; Wohlfahrt P; Pol M; Hlavacek D; Konarik M; Szarszoi O; Netuka I; Pitha J
    ESC Heart Fail; 2021 Oct; 8(5):4288-4295. PubMed ID: 34346192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatility and flow patterns across macro- and microcirculatory arteries of continuous-flow left ventricular assist device patients.
    Stöhr EJ; Ji R; Mondellini G; Braghieri L; Akiyama K; Castagna F; Pinsino A; Cockcroft JR; Silverman RH; Trocio S; Zatvarska O; Konofagou E; Apostolakis I; Topkara VK; Takayama H; Takeda K; Naka Y; Uriel N; Yuzefpolskaya M; Willey JZ; McDonnell BJ; Colombo PC
    J Heart Lung Transplant; 2023 Sep; 42(9):1223-1232. PubMed ID: 37098374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
    Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
    JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.
    Kanwar MK; Rajagopal K; Itoh A; Silvestry SC; Uriel N; Cleveland JC; Salerno CT; Horstmanshof D; Goldstein DJ; Naka Y; Bailey S; Gregoric ID; Chuang J; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Jun; 39(6):529-537. PubMed ID: 32279919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid artery structure and hemodynamics and their association with adverse vascular events in left ventricular assist device patients.
    Kiyatkin ME; Zuver AM; Gaudig A; Javaid A; Mabasa M; Royzman E; McDonnell BJ; Yuzefpolskaya M; Colombo PC; Stöhr EJ; Willey JZ
    J Artif Organs; 2021 Jun; 24(2):182-190. PubMed ID: 33459911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Artificial Pulsatility on the Peripheral Vasculature in Patients With Continuous-Flow Ventricular Assist Devices.
    Ivak P; Netuka I; Tucanova Z; Wohlfahrt P; Konarik M; Szarszoi O; Novakova S; Kubanek M; Lanska V; Pitha J
    Can J Cardiol; 2021 Oct; 37(10):1578-1585. PubMed ID: 34090978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Ventricular Assist Device Flow Pattern Analysis Using a Novel Model Incorporating Left Ventricular Pulsatility.
    Grinstein J; Torii R; Bourantas CV; Garcia-Garcia HM
    ASAIO J; 2021 Jul; 67(7):724-732. PubMed ID: 33528162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation.
    Kang G; Ha R; Banerjee D
    J Heart Lung Transplant; 2016 Jan; 35(1):67-73. PubMed ID: 26212656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral vasoreactivity in HeartMate 3 patients.
    Stöhr EJ; Ji R; Akiyama K; Mondellini G; Braghieri L; Pinsino A; Cockcroft JR; Yuzefpolskaya M; Amlani A; Topkara VK; Takayama H; Naka Y; Uriel N; Takeda K; Colombo PC; McDonnell BJ; Willey JZ
    J Heart Lung Transplant; 2021 Aug; 40(8):786-793. PubMed ID: 34134913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
    Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular function in continuous-flow left ventricular assist device recipients: effect of a single pulsatility treatment session.
    Hydren JR; Gifford JR; Jarrett CL; Park SH; Shields KL; Broxterman RM; Kithas AC; Bisconti AV; Thurston TS; Ratchford SM; Wray DW; Stehlik J; Selzman CH; Drakos SG; Richardson RS
    Am J Physiol Regul Integr Comp Physiol; 2021 Apr; 320(4):R425-R437. PubMed ID: 33438517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis.
    Coffin ST; Haglund NA; Davis ME; Xu M; Dunlay SM; Cowger JA; Shah P; Aaronson KD; Pagani FD; Stulak JM; Maltais S;
    J Heart Lung Transplant; 2015 Dec; 34(12):1578-85. PubMed ID: 26522376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
    Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy.
    Yanagida R; Czer LS; Mirocha J; Rafiei M; Esmailian F; Moriguchi J; Kobashigawa JA; Trento A
    Transplant Proc; 2014 Dec; 46(10):3575-9. PubMed ID: 25498092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.
    Wever-Pinzon O; Selzman CH; Drakos SG; Saidi A; Stoddard GJ; Gilbert EM; Labedi M; Reid BB; Davis ES; Kfoury AG; Li DY; Stehlik J; Bader F
    Circ Heart Fail; 2013 May; 6(3):517-26. PubMed ID: 23479562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients.
    Jain R; Habal MV; Clerkin KJ; Latif F; Restaino SW; Zorn E; Takeda K; Naka Y; Yuzefpolskaya M; Farr MA; Colombo PC; Sayer GT; Uriel N; Topkara VK
    ASAIO J; 2022 Feb; 68(2):226-232. PubMed ID: 33883507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Acoustic Biomarker of Quality of Life in Left Ventricular Assist Device Recipients.
    Mainsah BO; Patel PA; Chen XJ; Olsen C; Collins LM; Karra R
    J Am Heart Assoc; 2021 Mar; 10(6):e018588. PubMed ID: 33660516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.